Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shigeru Shibata

Showing results (11-20 of 162) with videos related to

Pageof 17
Sort By:
Hypertension Research : Official Journal of the Japanese Society of Hypertension|April 24, 2024
Another evidence that supports the continued use of RAS inhibitors in end-stage kidney diseasesOsamu Yamazaki, Shigeru Shibata
Hypertension Research : Official Journal of the Japanese Society of Hypertension|August 18, 2025
Renal-adipose neural circuit underlies the weight-lowering effects of sodium-glucose co-transporter 2 inhibitorsMinoru Yasukawa, Shigeru Shibata
Hypertension Research : Official Journal of the Japanese Society of Hypertension|November 15, 2024
Nonsteroidal MR antagonism in PA: clinical outcomes and unanswered questionsDaigoro Hirohama, Shigeru Shibata
American Journal of Hypertension|August 18, 2021
Updates on Renin-Angiotensin System Blockers in Hypertensive Patients With COVID-19Shigeru Shibata, Takuya Kishi
Hypertension Research : Official Journal of the Japanese Society of Hypertension|December 22, 2023
Anti-adrenergic agents and the risk of postoperative acute kidney injuryShinichiro Asakawa, Shigeru Shibata
Current Hypertension Reports|January 6, 2011
The kidneys and aldosterone/mineralocorticoid receptor system in salt-sensitive hypertensionShigeru Shibata, Toshiro Fujita
Hypertension Research : Official Journal of the Japanese Society of Hypertension|February 27, 2023
Current situation of telemedicine research for cardiovascular risk in JapanShigeru Shibata, Satoshi Hoshide
Hypertension Research : Official Journal of the Japanese Society of Hypertension|July 15, 2022
Severe COVID-19 and preexisting hypertension: a matter of age?Osamu Yamazaki, Shigeru Shibata
International Journal of Molecular Sciences|May 13, 2023
Mineralocorticoid Receptor Antagonists for Preventing Chronic Kidney Disease Progression: Current Evidence and Future ChallengesWataru Fujii, Shigeru Shibata
Hypertension Research : Official Journal of the Japanese Society of Hypertension|April 10, 2024
Mitochondrial fission: a new mechanism of hypertension and cardiovascular remodeling induced by Angiotensin IIKohei Ueda, Shigeru Shibata
Pageof 17

Showing results (11-20 of 162) with videos related to

Sort By:
Pageof 17
Hypertension Research : Official Journal of the Japanese Society of Hypertension|April 24, 2024
Another evidence that supports the continued use of RAS inhibitors in end-stage kidney diseasesOsamu Yamazaki, Shigeru Shibata
Hypertension Research : Official Journal of the Japanese Society of Hypertension|August 18, 2025
Renal-adipose neural circuit underlies the weight-lowering effects of sodium-glucose co-transporter 2 inhibitorsMinoru Yasukawa, Shigeru Shibata
Hypertension Research : Official Journal of the Japanese Society of Hypertension|November 15, 2024
Nonsteroidal MR antagonism in PA: clinical outcomes and unanswered questionsDaigoro Hirohama, Shigeru Shibata
American Journal of Hypertension|August 18, 2021
Updates on Renin-Angiotensin System Blockers in Hypertensive Patients With COVID-19Shigeru Shibata, Takuya Kishi
Hypertension Research : Official Journal of the Japanese Society of Hypertension|December 22, 2023
Anti-adrenergic agents and the risk of postoperative acute kidney injuryShinichiro Asakawa, Shigeru Shibata
Current Hypertension Reports|January 6, 2011
The kidneys and aldosterone/mineralocorticoid receptor system in salt-sensitive hypertensionShigeru Shibata, Toshiro Fujita
Hypertension Research : Official Journal of the Japanese Society of Hypertension|February 27, 2023
Current situation of telemedicine research for cardiovascular risk in JapanShigeru Shibata, Satoshi Hoshide
Hypertension Research : Official Journal of the Japanese Society of Hypertension|July 15, 2022
Severe COVID-19 and preexisting hypertension: a matter of age?Osamu Yamazaki, Shigeru Shibata
International Journal of Molecular Sciences|May 13, 2023
Mineralocorticoid Receptor Antagonists for Preventing Chronic Kidney Disease Progression: Current Evidence and Future ChallengesWataru Fujii, Shigeru Shibata
Hypertension Research : Official Journal of the Japanese Society of Hypertension|April 10, 2024
Mitochondrial fission: a new mechanism of hypertension and cardiovascular remodeling induced by Angiotensin IIKohei Ueda, Shigeru Shibata
Pageof 17